섬망 환자에서 Quetiapine과 Haloperidol의 치료 효과 비교 : 전향적, 무작위 연구
Comparison on the Efficacy of Quetiapine versus Haloperidol in the Treatment of Delirium : Prospective, Randomized Trial
2
조회
0
다운로드
6
인용
0
참고문헌
초록
Abstract
The purpose of this study is to examine the efficacy and side effects of quetiapine and haloperidol for the treatment of symptoms of delirium. One hundred and seven patients with delirium were recruited and randomly assigned to receive a flexible-dose regimen of quetiapine or haloperidol over 7 days and seventy-seven patients completed the study(quetiapine group N=40, haloperidol group N=37). The severity of delirium was assessed by using Memorial Delirium Assessment Scale(MDAS) scores, the psychiatric and behavioral symptoms were assessed by Neurobehavioral Rating Scale(NRS) scores, and the cognitive status was measured by Mini-mental state examination Korean version(MMSE-K) scores. The side effects were measured by Drug Induced Extrapyramidal Symptoms Scale(DIEPSS) scores. MDAS scores significantly improved in both treatment groups. NRS scores also significantly improved in both treatment group, but the group-by-time effect approached significance, likely caused by the greater decrease in scores of the quetiapine group. MMSE-K scores significantly improved only in the quetiapine group. Side effects associated with treatment were not significant in either treatment group. This study suggests that quetiapine is efficacious as haloperidol in the treatment of delirium. In particular, quetiapine seems to improve psychiatric and behavioral problems of delirium and was more effective than haloperidol in cognitive improvement.
참고문헌 (30)
- Brown TM, "Delirium", BMJ, 325, pp.644~647 (2002)
- Lipowski ZJ, "Delirium(Acute confusional states)", JAMA, 258, pp.1789~1792 (1987)
- Strain JJ, "Cost offset from a psychiatric consultation-liaison intervention with elderly hip fracture patients", Am J Psychiatry, 148, pp.1044~1049 (1991)
- Sadock BJ, "Kaplan and Sadock's comprehensive textbook of psychiatry, 8th edition", pp.1054~1059 (2005), Williams & Wilkins
- "American Psychiatric Association. Practice Guidelines for the Treatment of Psychiatric Disorders", pp.29~66 (2004), American Psychiatric Association
- Casey DE, "Acute extrapyramidal syndrome. in: Contemporary Issues in the Treatment of Schizophrenia", pp.535~550 (1995), American Psychiatric Press
- Savaskan E, "Treatment of behavioral, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs quetiapine", Int J Neuropsychopharmacol, 9, pp.507~516 (2006)
- Tyson PJ, "Are the cognitive effects of atypical antipsychotics influenced by their affinity to 5HT-2A receptors?", Int J Neurosci, 114, pp.593~611 (2004)
- Velligan DI, "Does cognitive function improve with quetiapine in comparison to haloperidol?", Schizophr Res, 53, pp.239~248 (2002)
- Voruganti LP, "Cognition, functioning and quality of life in schizophrenia treatment: Results of a one-year randomized controlled trial of olanzapine and quetiapine", Schizophr Res, 96, pp.146~155 (2007)
- Riedel M, "Effects of risperidone and quetiapine on cognition in patients with schizophrenia and premoninantly negative symptoms", Eur Arch Psychiatry Clin Neurosci, 257, pp.360~370 (2007)
- Sasaki Y, "A prospective, open-label , flexible dose study of quetiapine in the treatment of delirium", J clin Psychiatry, 64, pp.1316~1321 (2003)
- Kim KY, "Treatment of delirium in older adults with quetiapine", J Geriatr Psychiatry Neurol, 16, pp.29~31 (2003)
- Pae CU, "A pilot trial of quetiapine for the treatment of patients with delirium", Hum Psychopharmacol, 19, pp.125~127 (2004)
- Schwartz TL, "Treatment of delirium with quetiapine", Prim Care Companion J Clin psychiatry, 2, pp.10~12 (2000)
- Choi HG, "A Prospective and Open-Label Trial of Quetiapine and Haloperidol in the Treatment of Delirium", Journal of Psychosomatic Medicine, 13, pp.85~94 (2005)
- Breitbart W, "Diagnosis and management of delirium in the terminally ill. in: Topics in palliative care, vol 5", Oxford University Press
- Wise M, "Delirium. in: Text of neuropsychiatry, 2nd ed", American Psychiatric Association
- Breitbart W, "Cohen K, Passik S. The Memorial Delirium Assessment Scale", J Pain Symptom Manage, 13, pp.128~137 (1997)
- Levin HS, "The Neurobehavioral Rating Scale: assessment of the behavioral sequeale of head injury by the clinician", J Neurol Neurosurg Psychiatry, 50, pp.183~193 (1987)
- Park JH, "Modification of the Mini-mental State Examination for use with the elderly in a non-western country: Part II. cut off points and their diagnostic validities", Int J Geriatr Psychiatry, 6, pp.875~882 (1991)
- Shaun T, "Use of serial Mini-Mental State Examinations to diagnose and monitor delirium in elderly hospital patien", J Am Geriatrics Soc, 53, pp.867~870 (2005)
- Inada T, "Evaluation and diagnosis of drug-induced extrapyramidal symptoms: commentary on the DIEPSS and guide to its usage" (1996), Seiwa Shoten Publishers
- Han CH, "A double blind trial of risperidone and haloperidol for the treatment of delirium", Psychosomatics, 45, pp.297~301 (2004)
- Breitbart W, "An open trial of olanzapine for the treatment of delirium in hospitalized cancer patients", Psychosomatics, 43, pp.174~182 (2002)
- Seitz DP, "Antipsychotics in the treatment of delirium: a systematic review", J Clin Psychiatry, 68, pp.11~21 (2007)
- Breitbart W, "A Double blind trial of haloperidol , chlopromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients", Am J Psychiatry, 153, pp.231~237 (1996)
- Torres R, "Use of quetiapine in delirium: case reports", Psychosomatics, 42, pp.347~349 (2001)
- Seitz DP, "Antipsychotics in the Treatment of delirium: A systematic review", J Clin Psychiatry, 68, pp.11~21 (2007)
- Kalisvaart KJ, "Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: a randomized placebo-controlled study", J Am Geriatr Soc, 53, pp.1658~1666 (2005)